Specjalistyczny Psychiatryczny Zespół Opieki Zdrowotnej W Łodzi
Łódź-Bałuty, Polen
Behandlung & Zugang
- Angebotene Behandlungenesketamine (Spravato)
- ZugangswegDurch ein nationales Programm übernommen
- Kosten & Übernahme (Registerstatus)Covered by NFZ (drug programme B.147)
- ErstattungNFZ drug programme B.147 - leczenie chorych na depresję lekooporną So funktioniert die Erstattung in Europa →
- Telefon42 71 55 918
- Websitehttps://babinski.home.pl/
Verwandte Einträge
Diese Einträge gehören zur selben Organisation. Sie werden separat geführt, weil jeder ein eigenes Programm oder ein eigener Standort ist.
- Standort in Łódź-GórnaSpecjalistyczny Psychiatryczny Zespół Opieki Zdrowotnej W Łodzi — Spravato®
Über diesen Anbieter
Specjalistyczny Psychiatryczny Zespol Opieki Zdrowotnej w Lodzi — the Babinski psychiatric hospital at ul. Aleksandrowska 159 — operates the Mental Health Centre Lodz-Baluty and, per NFZ data, is one of the contracted centres of drug programme B.147, which provides esketamine (Spravato) free of charge for treatment-resistant depression. Per its own site, it also runs adult inpatient wards, a psychiatric admissions unit, outpatient clinics and day wards, psychogeriatric, detox and forensic psychiatry wards, child and adolescent psychiatry, and online registration.
Leistungen & Programme
- Mental Health Centre Lodz-Baluty (adult community mental health care)
- Mental Health Centre Lodz-Gorna
- Psychiatric admissions unit (Izba Przyjec), tel. 42 71 55 898
- Adult inpatient psychiatric wards
- Psychogeriatric ward
- Detoxification ward
- Forensic psychiatry wards
- Child and adolescent psychiatric wards
- Outpatient clinics (poradnie)
- Day wards (oddzialy dzienne)
- Community Mental Health Centre for Children and Adolescents
- Online registration portal
Häufige Fragen
How do I get into the esketamine (Spravato) programme at this centre?
Treatment runs under Poland's NFZ drug programme B.147. You need a referral from a psychiatrist; the centre's programme team then checks the qualification criteria — adults aged 18-75 with treatment-resistant depression, meaning no response to at least two different antidepressants used adequately in the current episode.
What does the programme cover?
Programme B.147 is fully funded by the NFZ: the esketamine nasal spray, its supervised administration at the centre and the required monitoring visits are covered, for a maximum of 34 weeks of treatment.
Where do I register?
The hospital's Mental Health Centre registration is available at 42 71 55 918, and the site also offers an online registration portal. Bring your psychiatrist's referral and treatment history documenting previous antidepressant trials.
Verifizierung
- Lizenz / RegisterNFZ B.147
- Quellehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Zuletzt verifiziert